BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21923243)

  • 21. Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model.
    Weingart JD; Thompson RC; Tyler B; Colvin OM; Brem H
    Int J Cancer; 1995 Sep; 62(5):605-9. PubMed ID: 7665233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma.
    Storm PB; Renard VM; Moriarity JL; Tyler B; Wilentz RE; Brem H; Weingart JD
    Cancer Chemother Pharmacol; 2004 Oct; 54(4):361-7. PubMed ID: 15197484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intralesionally implanted cisplatin plus systemic carmustine for the treatment of brain tumor in rats.
    Kong Q; Kleinschmidt-DeMasters BK; Lillehei KO
    J Surg Oncol; 1998 Oct; 69(2):76-82. PubMed ID: 9808509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
    Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
    Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.
    Yung WK; Albright RE; Olson J; Fredericks R; Fink K; Prados MD; Brada M; Spence A; Hohl RJ; Shapiro W; Glantz M; Greenberg H; Selker RG; Vick NA; Rampling R; Friedman H; Phillips P; Bruner J; Yue N; Osoba D; Zaknoen S; Levin VA
    Br J Cancer; 2000 Sep; 83(5):588-93. PubMed ID: 10944597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal temozolomide drug delivery using convection enhanced delivery.
    Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y
    J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.
    Sugiyama S; Yamashita Y; Kikuchi T; Saito R; Kumabe T; Tominaga T
    J Neurooncol; 2007 Mar; 82(1):41-7. PubMed ID: 17031554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracranial microcapsule drug delivery device for the treatment of an experimental gliosarcoma model.
    Scott AW; Tyler BM; Masi BC; Upadhyay UM; Patta YR; Grossman R; Basaldella L; Langer RS; Brem H; Cima MJ
    Biomaterials; 2011 Apr; 32(10):2532-9. PubMed ID: 21220172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal assessment of regional directed delivery in a rodent malignant glioma model.
    Kondo A; Goldman S; Lulla RR; Mania-Farnell B; Vanin EF; Sredni ST; Rajaram V; Soares MB; Tomita T
    J Neurosurg Pediatr; 2009 Dec; 4(6):592-8. PubMed ID: 19951051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor efficacy improved by local delivery of species-specific endostatin.
    Huszthy PC; Brekken C; Pedersen TB; Thorsen F; Sakariassen PO; Skaftnesmo KO; Haraldseth O; Lønning PE; Bjerkvig R; Enger PO
    J Neurosurg; 2006 Jan; 104(1):118-28. PubMed ID: 16509155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local delivery of cancer-cell glycolytic inhibitors in high-grade glioma.
    Wicks RT; Azadi J; Mangraviti A; Zhang I; Hwang L; Joshi A; Bow H; Hutt-Cabezas M; Martin KL; Rudek MA; Zhao M; Brem H; Tyler BM
    Neuro Oncol; 2015 Jan; 17(1):70-80. PubMed ID: 25053853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local convection-enhanced delivery of chemotherapeutic agent transiently opens blood-brain barrier and improves efficacy of systemic chemotherapy in intracranial xenograft tumor model.
    Nakamura T; Saito R; Sugiyama S; Sonoda Y; Kumabe T; Tominaga T
    Cancer Lett; 2011 Nov; 310(1):77-83. PubMed ID: 21763069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model.
    Murphy S; Davey RA; Gu XQ; Haywood MC; McCann LA; Mather LE; Boyle FM
    J Neurooncol; 2007 Nov; 85(2):181-9. PubMed ID: 17534579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Captopril inhibits Matrix Metalloproteinase-2 and extends survival as a temozolomide adjuvant in an intracranial gliosarcoma model.
    Pinheiro L; Perdomo-Pantoja A; Casaos J; Huq S; Paldor I; Vigilar V; Mangraviti A; Wang Y; Witham TF; Brem H; Tyler B
    Clin Neurol Neurosurg; 2021 Aug; 207():106771. PubMed ID: 34198223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracranial microcapsule chemotherapy delivery for the localized treatment of rodent metastatic breast adenocarcinoma in the brain.
    Upadhyay UM; Tyler B; Patta Y; Wicks R; Spencer K; Scott A; Masi B; Hwang L; Grossman R; Cima M; Brem H; Langer R
    Proc Natl Acad Sci U S A; 2014 Nov; 111(45):16071-6. PubMed ID: 25349381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model.
    Saito R; Bringas JR; Panner A; Tamas M; Pieper RO; Berger MS; Bankiewicz KS
    Cancer Res; 2004 Oct; 64(19):6858-62. PubMed ID: 15466173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model.
    Huang TT; Hlavaty J; Ostertag D; Espinoza FL; Martin B; Petznek H; Rodriguez-Aguirre M; Ibañez CE; Kasahara N; Gunzburg W; Gruber HE; Pertschuk D; Jolly DJ; Robbins JM
    Cancer Gene Ther; 2013 Oct; 20(10):544-51. PubMed ID: 23969884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed onset of paresis in rats with experimental intramedullary spinal cord gliosarcoma following intratumoral administration of the paclitaxel delivery system OncoGel.
    Tyler BM; Hdeib A; Caplan J; Legnani FG; Fowers KD; Brem H; Jallo G; Pradilla G
    J Neurosurg Spine; 2012 Jan; 16(1):93-101. PubMed ID: 22208429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of intralesionally administered cisplatin-impregnated biodegradable polymer for the treatment of 9L gliosarcoma in the rat.
    Lillehei KO; Kong Q; Withrow SJ; Kleinschmidt-DeMasters B
    Neurosurgery; 1996 Dec; 39(6):1191-7; discussion 1197-9. PubMed ID: 8938774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals.
    Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC
    Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.